This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox's (CLX) Growth Strategies Seem Encouraging: Here's Why
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy bodes well. The company's pricing and cost-saving initiatives are aiding margins and, in turn, profitability.
TreeHouse Foods' (THS) Pricing & Operational Excellence Aid
by Zacks Equity Research
TreeHouse Foods (THS) is strategically advancing through effective pricing, portfolio management and supply-chain efficiencies.
Kraft Heinz (KHC) Up on Transformation & Pricing Actions
by Zacks Equity Research
Kraft Heinz (KHC) is undertaking strategic pricing initiatives to improve performance. Management is committed to accelerating its profit and enhancing the long-term shareholders' value.
Campbell Soup (CPB) Shows Strategic Resilience Amid Challenges
by Zacks Equity Research
Campbell Soup's (CPB) focus on maintaining competitive pricing, sustaining marketing and innovation initiatives and adhering to a balanced spending approach bodes well amid industry woes.
Pilgrim's Pride's (PPC) Operational Excellence Drives Growth
by Zacks Equity Research
Pilgrim's Pride's (PPC) strategic approach across global markets led to significant profitability and growth, underpinned by innovative products, strong partnerships and effective pricing strategies.
Take the Zacks Approach to Beat the Market: Shopify, Fastenal, Block in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Kimberly-Clark (KMB) Benefits From Saving Plans Amid High Costs
by Zacks Equity Research
Kimberly-Clark (KMB) is benefiting from a focus on revenue growth management and pricing actions amid an inflationary environment.
Lamb Weston (LW) Rewards Investors With a Dividend Hike
by Zacks Equity Research
Lamb Weston (LW) hikes its quarterly dividend by 29% to 36 cents per share. The hiked dividend is payable on Mar 1, 2024.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Medifast (MED) Collaborates With LifeMD, Discontinues Dividend
by Zacks Equity Research
Medifast (MED) penetrates the medically supported weight loss market via a collaboration with LifeMD, Inc. (LFMD). The company discontinues quarterly cash dividends.
Foodservice Unit Aids Tyson Foods (TSN), Soft Pork Sales Ail
by Zacks Equity Research
Tyson Foods (TSN) is impressed with its foodservice portfolio and is likely to keep gaining momentum. However, weakness in the Pork segment from supply-and-demand imbalances hurts.
United Natural (UNFI) Poised on Transformation Initiatives
by Zacks Equity Research
United Natural (UNFI) is strategically focusing on operational enhancements and efficiency to boost profitability despite retail sector challenges and a changing economic landscape.
Wall Street Analysts Think Celsius Holdings Inc. (CELH) Could Surge 124.19%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Celsius Holdings Inc. (CELH) points to a 124.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Flowers Foods (FLO) Strategic Priorities Aid Amid High Costs
by Zacks Equity Research
Flowers Foods (FLO) looks well placed on brand focus, margin prioritization, and engagement in mergers and acquisitions amid high SD&A costs.
Here is What to Know Beyond Why Celsius Holdings Inc. (CELH) is a Trending Stock
by Zacks Equity Research
Celsius Holdings Inc. (CELH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is battling escalating macroeconomic pressures, which are hampering key markets of the core business. Unfavorable currency translations remain a major concern.
Service Corporation (SCI) Sees Growth in Cemetery Revenues
by Zacks Equity Research
Service Corporation (SCI) gains from growing Cemetery segment revenues. However, funeral volumes are expected to decline for 2023 due to the pull-forward impact of the pandemic.
The J.M. Smucker's (SJM) Core Priorities Aid, SD&A Costs Hurt
by Zacks Equity Research
The J.M. Smucker (SJM) looks well placed on strong brand demand, net price realization and core priorities such as reshaping the portfolio amid elevated SD&A costs.
Grocery Outlet (GO) Gains on Value Proposition & Market Growth
by Zacks Equity Research
With a strong focus on customer diversity, operational efficiency and sustainable growth, Grocery Outlet (GO) continues to solidify its position in the grocery retail sector.
Casey's (CASY) Q2 Earnings Top, Inside Same-Store Sales Rise
by Zacks Equity Research
Casey's (CASY) second-quarter results reflect strength in grocery and general merchandise as well as food and dispensed beverage categories.
Top 5 Consumer Staples Stocks for a Stable Portfolio in 2024
by Nalak Das
We have narrowed our search to five consumer staples stocks with strong growth potential for 2024. These are: CELH, PG, KHC, TAP, ELF.
Post Holdings (POST) Ups Adjusted EBITDA View on Latest Buyout
by Zacks Equity Research
Post Holdings (POST) updates its adjusted EBITDA guidance for fiscal 2024, which includes contributions from the Perfection Pet Foods acquisition.
BJ's Wholesale (BJ) Rides on Value Proposition & Digitization
by Zacks Equity Research
BJ's Wholesale Club's (BJ) growth strategies, better price management, decent membership trends and digitization are likely to keep supporting comparable sales trends.
Are Consumer Staples Stocks Lagging Celsius (CELH) This Year?
by Zacks Equity Research
Here is how Celsius Holdings Inc. (CELH) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About Celsius Holdings Inc. (CELH): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Celsius Holdings Inc. (CELH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?